Castle Biosciences CSTL
NASDAQ CSTL
$34.37 +1.22 (+3.68%)
At close: Oct 21, 2026 · 4:00 PM EDT

Castle Biosciences (CSTL) EV to EBIT (2019 - 2024)

Updated

Castle Biosciences' (CSTL) EV to EBIT was 53.74 for Q4 2024.

Analysis

Castle Biosciences (CSTL) EV to EBIT (2019 - 2024) Analysis & Trends

Dating back to Q3 2019, Castle Biosciences' EV to EBIT record includes 5 quarters.

  • The Q4 2024 figure ranks as the highest quarterly EV to EBIT since Q2 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 101.22 Bn 97.23 Bn -
2 Natera 59.29 Bn 54.98 Bn 485.19 Mn
3 Quest Diagnostics 26.56 Bn 24.69 Bn 1.03 Bn
4 Labcorp Holdings 26.41 Bn 24.16 Bn 1.11 Bn
5 Tenet Healthcare 22.49 Bn 11.49 Bn -
6 Guardant Health 22.12 Bn 18.19 Bn 219.03 Mn
7 BrightSpring Health Services 12.91 Bn 11.24 Bn 492.75 Mn
8 Fresenius Medical Care AG 12.56 Bn 4.51 Bn 1.52 Bn
9 Tempus AI 12.17 Bn 9.20 Bn 246.50 Mn
10 Castle Biosciences 1.05 Bn -67.48 Mn 79.85 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 53.74
Jun 30, 2020 74.05
Mar 31, 2020 47.68
Dec 31, 2019 26.77
Sep 30, 2019 14.37
API Access

Castle Biosciences EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=CSTL&period=max&api_key=YOUR_API_KEY